A New Concept for Axillary Treatment of Primary Breast Cancer Using Indocyanine Green Fluorescence Imaging


First author

Study type

Patients (N)

SLN technique

Identification rate (%)

False-negative rate (%)

SLNs (N)

References

Kitai

Cohort

18

fICG

94

NA

2.8

[6]

Tagaya

Cohort

25

fICG

100

0

5.4

Am J Surg, 2008.
   
Dye

92

25

2.3
 
Murawa

Cohort

30

fICG

97

10

1.75

Br J Surg, 2009.
  
20

RI

85

23

1.35
 
Abe

Cohort

128

fICG

100

0

3.1

Surg Today, 2011.
   
Dye

65.4

42

1
 
Hojo

Cohort

113

fICG

100

NA

3

Breast, 2010.
   
Dye

92.9

NA

1.9
   
29

fICG

93.1

NA

3
    
RI

100

NA

2
 
Hirche

Cohort

43

fICG

97.7

NA

2

Breast Cancer Res Treat, 2010.

Aoyama

Cohort

312

fICG

100

NA

3.41

World J Surg Oncol, 2011.

Tagaya

Cohort

50

fICG + dye

100

NA

3.7

World J Surg, 2011.

Wishart

Cohort

100

fICG

100

0

1.93

Eur J Surg Oncol, 2012.
   
RI

91.3

0

1.5
    
Dye

99

0

1.84
 
Polom

Cohort

28

fICG + RI

96

NA

2

Eur J Surg Oncol, 2012.
  
21

fICG:HAS + RI

100

NA

2
 
Hirche

Cohort

47

fICG

97.9

5.3

2

J Surg Oncol, 2012.

Van der Vorst

RCT

12

fICG

100

NA

1.6

[7]
   
RI

100

NA
     
Dye

84

NA
    
12

fICG

100

NA

1.5
    
RI

100

NA
  
Schaafsma

Cohort

32

fICG

100

NA

1.5

Br J Surg, 2013.
   
RI

100

NA
     
Dye

88

NA
  
Sugie

Cohort

99

fICG

99

NA

3.4

[9]
   
Dye

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 20, 2016 | Posted by in GENERAL RADIOLOGY | Comments Off on A New Concept for Axillary Treatment of Primary Breast Cancer Using Indocyanine Green Fluorescence Imaging

Full access? Get Clinical Tree

Get Clinical Tree app for offline access